VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 510 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2014. The put-call ratio across all filers is 1.37 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $297,000 | -85.6% | 11,293 | -44.4% | 0.09% | -93.3% |
| Q4 2015 | $2,063,000 | -100.0% | 20,293 | -14.7% | 1.32% | -55.4% |
| Q3 2015 | $4,244,195,000 | +75432.9% | 23,793 | -5.9% | 2.97% | -35.2% |
| Q2 2015 | $5,619,000 | +6.0% | 25,293 | -5.2% | 4.59% | +3.7% |
| Q1 2015 | $5,302,000 | +36.2% | 26,693 | -1.8% | 4.42% | +33.5% |
| Q4 2014 | $3,892,000 | +3.4% | 27,193 | -5.2% | 3.31% | -4.4% |
| Q3 2014 | $3,765,000 | -9.5% | 28,693 | -13.0% | 3.46% | -16.5% |
| Q2 2014 | $4,161,000 | -4.5% | 32,989 | -0.2% | 4.15% | +0.0% |
| Q1 2014 | $4,356,000 | -99.9% | 33,039 | -0.0% | 4.15% | +18.1% |
| Q4 2013 | $3,880,540,000 | +157006.9% | 33,054 | +15.2% | 3.51% | +15.2% |
| Q2 2013 | $2,470,000 | – | 28,693 | – | 3.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |